Philadelphia 76ers · — · #—
—
| Period | GP | MIN | PTS | REB | AST | PRA | STL | BLK | TOV | 2PM | 2PA | 2P% | 3PM | 3PA | 3P% | FTM | FTA | FT% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Last 3 | 3 | 35.9 | 26.3 | 10.7 | 3.7 | 40.7 | 0.0 | 2.7 | 2.7 | 6.3 | 14.3 |
| 44.2% |
| 1.7 |
| 6.0 |
| 27.8% |
| 8.7 |
| 10.3 |
| 83.9% |
| Last 5 | 5 | 34.3 | 28.6 | 8.8 | 4.0 | 41.4 | 0.0 | 2.2 | 2.2 | 6.6 | 14.0 | 47.1% | 2.2 | 5.4 | 40.7% | 8.8 | 10.6 | 83.0% |
| Last 10 | 10 | 33.3 | 28.8 | 8.2 | 4.2 | 41.2 | 0.3 | 1.5 | 2.3 | 7.3 | 14.3 | 51.0% | 2.0 | 4.8 | 41.7% | 8.2 | 9.5 | 86.3% |
| Last 20 | 20 | 33.9 | 29.8 | 8.4 | 4.5 | 42.8 | 0.6 | 1.1 | 3.0 | 8.1 | 15.2 | 52.8% | 1.8 | 4.2 | 41.2% | 8.4 | 9.8 | 86.7% |
| Season | 38 | 31.6 | 26.9 | 7.7 | 3.9 | 38.5 | 0.6 | 1.2 | 2.9 | 7.6 | 14.2 | 53.5% | 1.4 | 4.2 | 33.3% | 7.5 | 8.8 | 85.4% |
high post-ups, high usage, high assist rate, low off-ball shooting
2025-26 season · fitted over 2022-23–2025-26
Style profile over 446 qualified players (8+ games, 10+ min/game). 100% is an identical profile; 50% is unrelated.
| Date | Matchup | W/L | MIN | PTS | REB | AST | STL | BLK | TOV | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | +/- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-06 | PHI @ SAS | L | 39.2 | 34 | 12 | 1 | 0 | 4 | 4 | 8 | 19 | 42.1% | 2 | 6 | 33.3% | 16 | 19 | 84.2% | -7.0 |
| 2026-04-03 | PHI vs. MIN | W | 34.5 | 19 | 13 | 7 | 0 | 3 | 1 | 6 | 17 | 35.3% | 1 | 6 | 16.7% | 6 | 7 | 85.7% | 15.0 |
| 2026-03-30 | PHI @ MIA | L | 34.1 | 26 | 7 | 3 | 0 | 1 | 3 | 10 | 25 | 40.0% | 2 | 6 | 33.3% | 4 | 5 | 80.0% | -18.0 |
| 2026-03-28 | PHI @ CHA | W | 35.8 | 29 | 6 | 2 | 0 | 2 | 0 | 8 | 19 | 42.1% | 3 | 6 | 50.0% | 10 | 13 | 76.9% | 5.0 |
| 2026-03-25 | PHI vs. CHI | W | 28.1 | 35 | 6 | 7 | 0 | 1 | 3 | 12 | 17 | 70.6% | 3 | 3 | 100.0% | 8 | 9 | 88.9% | 33.0 |
| 2026-02-26 | PHI vs. MIA | W | 31.2 | 26 | 11 | 4 | 1 | 0 | 2 | 8 | 20 | 40.0% | 2 | 6 | 33.3% | 8 | 9 | 88.9% | 0.0 |
| 2026-02-24 | PHI @ IND | W | 26.3 | 27 | 6 | 5 | 0 | 1 | 4 | 11 | 17 | 64.7% | 1 | 4 | 25.0% | 4 | 5 | 80.0% | -1.0 |
| 2026-02-07 | PHI @ PHX | W | 33.0 | 33 | 9 | 3 | 0 | 1 | 2 | 9 | 19 | 47.4% | 4 | 7 | 57.1% | 11 | 13 | 84.6% | -10.0 |
| 2026-02-05 | PHI @ LAL | L | 38.6 | 35 | 7 | 7 | 1 | 2 | 3 | 13 | 19 | 68.4% | 1 | 2 | 50.0% | 8 | 8 | 100.0% | 7.0 |
| 2026-02-02 | PHI @ LAC | W | 32.2 | 24 | 5 | 3 | 1 | 0 | 1 | 8 | 19 | 42.1% | 1 | 2 | 50.0% | 7 | 7 | 100.0% | 2.0 |
| 2026-01-31 | PHI vs. NOP | W | 39.0 | 40 | 11 | 4 | 1 | 2 | 5 | 13 | 27 | 48.1% | 3 | 5 | 60.0% | 11 | 14 | 78.6% | 16.0 |
| 2026-01-29 | PHI vs. SAC | W | 35.9 | 37 | 5 | 8 | 1 | 1 | 2 | 13 | 21 | 61.9% | 1 | 2 | 50.0% | 10 | 13 | 76.9% | 9.0 |
| 2026-01-27 | PHI vs. MIL | W | 29.1 | 29 | 9 | 5 | 1 | 0 | 2 | 11 | 24 | 45.8% | 1 | 4 | 25.0% | 6 | 6 | 100.0% | 6.0 |
| 2026-01-24 | PHI vs. NYK | L | 36.4 | 38 | 11 | 5 | 0 | 1 | 4 | 13 | 21 | 61.9% | 3 | 5 | 60.0% | 9 | 12 | 75.0% | -3.0 |
| 2026-01-22 | PHI vs. HOU | W | 45.6 | 32 | 15 | 10 | 1 | 1 | 5 | 10 | 19 | 52.6% | 1 | 3 | 33.3% | 11 | 12 | 91.7% | 21.0 |
| 2026-01-19 | PHI vs. IND | W | 33.3 | 30 | 9 | 4 | 0 | 0 | 1 | 10 | 17 | 58.8% | 1 | 1 | 100.0% | 9 | 10 | 90.0% | 3.0 |
| 2026-01-16 | PHI vs. CLE | L | 33.1 | 33 | 5 | 3 | 0 | 1 | 1 | 10 | 22 | 45.5% | 2 | 3 | 66.7% | 11 | 12 | 91.7% | 9.0 |
| 2026-01-14 | PHI vs. CLE | L | 24.9 | 20 | 4 | 3 | 1 | 1 | 6 | 7 | 14 | 50.0% | 2 | 5 | 40.0% | 4 | 4 | 100.0% | -18.0 |
| 2026-01-12 | PHI @ TOR | W | 35.7 | 27 | 8 | 4 | 2 | 0 | 7 | 9 | 17 | 52.9% | 1 | 6 | 16.7% | 8 | 8 | 100.0% | 12.0 |
| 2026-01-09 | PHI @ ORL | W | 31.4 | 22 | 9 | 3 | 1 | 1 | 4 | 7 | 17 | 41.2% | 0 | 3 | 0.0% | 8 | 9 | 88.9% | 4.0 |
| 2026-01-07 | PHI vs. WAS | W | 25.4 | 28 | 7 | 2 | 0 | 2 | 2 | 10 | 14 | 71.4% | 1 | 2 | 50.0% | 7 | 8 | 87.5% | 27.0 |
| 2026-01-05 | PHI vs. DEN | L | 40.0 | 32 | 10 | 2 | 0 | 1 | 6 | 13 | 22 | 59.1% | 1 | 4 | 25.0% | 5 | 5 | 100.0% | 8.0 |
| 2026-01-03 | PHI @ NYK | W | 33.1 | 26 | 10 | 5 | 0 | 0 | 3 | 9 | 15 | 60.0% | 0 | 1 | 0.0% | 8 | 12 | 66.7% | 9.0 |
| 2026-01-01 | PHI @ DAL | W | 35.3 | 22 | 4 | 6 | 0 | 1 | 2 | 9 | 18 | 50.0% | 0 | 3 | 0.0% | 4 | 5 | 80.0% | 9.0 |
| 2025-12-30 | PHI @ MEM | W | 38.1 | 34 | 10 | 8 | 1 | 2 | 4 | 11 | 28 | 39.3% | 1 | 6 | 16.7% | 11 | 12 | 91.7% | -5.0 |
| 2025-12-26 | PHI @ CHI | L | 32.2 | 31 | 5 | 1 | 0 | 1 | 2 | 10 | 19 | 52.6% | 2 | 4 | 50.0% | 9 | 9 | 100.0% | 2.0 |
| 2025-12-23 | PHI vs. BKN | L | 31.5 | 27 | 6 | 4 | 0 | 2 | 3 | 8 | 13 | 61.5% | 1 | 1 | 100.0% | 10 | 12 | 83.3% | 1.0 |
| 2025-12-14 | PHI @ ATL | L | 30.2 | 22 | 14 | 1 | 1 | 2 | 3 | 8 | 20 | 40.0% | 1 | 3 | 33.3% | 5 | 6 | 83.3% | -8.0 |
| 2025-12-12 | PHI vs. IND | W | 31.9 | 39 | 9 | 3 | 1 | 0 | 3 | 12 | 23 | 52.2% | 2 | 8 | 25.0% | 13 | 18 | 72.2% | 16.0 |
| 2025-12-07 | PHI vs. LAL | L | 30.3 | 16 | 7 | 2 | 1 | 1 | 0 | 4 | 21 | 19.0% | 0 | 6 | 0.0% | 8 | 8 | 100.0% | 11.0 |
| 2025-12-04 | PHI vs. GSW | W | 25.2 | 12 | 6 | 3 | 0 | 1 | 3 | 5 | 13 | 38.5% | 0 | 5 | 0.0% | 2 | 2 | 100.0% | 2.0 |
| 2025-11-30 | PHI vs. ATL | L | 30.0 | 18 | 4 | 2 | 1 | 1 | 2 | 6 | 14 | 42.9% | 0 | 3 | 0.0% | 6 | 8 | 75.0% | -11.0 |
| 2025-11-08 | PHI vs. TOR | W | 26.0 | 29 | 6 | 4 | 0 | 1 | 2 | 10 | 16 | 62.5% | 1 | 4 | 25.0% | 8 | 9 | 88.9% | 15.0 |
| 2025-11-04 | PHI @ CHI | L | 25.6 | 20 | 6 | 2 | 3 | 4 | 3 | 7 | 21 | 33.3% | 1 | 6 | 16.7% | 5 | 6 | 83.3% | 1.0 |
| 2025-10-31 | PHI vs. BOS | L | 25.1 | 20 | 6 | 3 | 0 | 2 | 4 | 6 | 13 | 46.2% | 1 | 2 | 50.0% | 7 | 7 | 100.0% | 2.0 |
| 2025-10-28 | PHI @ WAS | W | 23.0 | 25 | 7 | 5 | 0 | 1 | 3 | 9 | 17 | 52.9% | 3 | 6 | 50.0% | 4 | 6 | 66.7% | 9.0 |
| 2025-10-25 | PHI vs. CHA | W | 20.1 | 20 | 2 | 4 | 2 | 0 | 4 | 7 | 11 | 63.6% | 3 | 6 | 50.0% | 3 | 5 | 60.0% | -2.0 |
| 2025-10-22 | PHI @ BOS | W | 20.3 | 4 | 6 | 2 | 0 | 1 | 0 | 1 | 9 | 11.1% | 0 | 4 | 0.0% | 2 | 2 | 100.0% | -16.0 |